William D. Claypool MD
Critical Care Medicine, Pleural Disease
Physician
Join to View Full Profile
4104 Meadow LnNewtown Square, PA 19073
Phone+1 484-420-4300
Dr. Claypool is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 1979 - 1981- University of Pennsylvania Health SystemResidency, Internal Medicine, 1977 - 1979
University of MinnesotaInternship, Internal Medicine, 1976 - 1977
Uconn School Of MedicineClass of 1976
Certifications & Licensure
PA State Medical License 1978 - 2026
IL State Medical License 1984 - 1993
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 84 citationsTargeted Antibiotic Delivery: Selective Siderophore Conjugation with Daptomycin Confers Potent Activity against Multidrug Resistant Acinetobacter baumannii Both in Vit...Manuka Ghosh, Patricia A. Miller, Ute Möllmann, William D. Claypool, Valerie A. Schroeder
Journal of Medicinal Chemistry. 2017-04-01 - 46 citationsAugmentation of rat alveolar macrophage migration by surfactant protein.Robert M. Hoffman, William D. Claypool, Sikandar L. Katyal, Gurmukh Singh, Robert M. Rogers
The American Review of Respiratory Disease. 2015-05-14 - 4 citationsBidisomide (SC-40230), a new antiarrhythmic agent: initial study of tolerability and pharmacokinetics.Richard L. Page, J. Marcus Wharton, William E. Wilkinson, Ina M Friedman, William D Claypool
Clinical Pharmacology and Therapeutics. 1992-04-01
Press Mentions
Shionogi Enters into a License and Research Collaboration for the Treatment of Mycobacterial Diseases with Hsiri Therapeutics, IncOctober 11th, 2019
Synthetic Sideromycins (Skepticism and Optimism): Selective Generation of Either Broad or Narrow Spectrum Gram-Negative AntibioticsMarch 27th, 2019
Grant Support
- Nhlbi Clinical Investigator Award ProgramNational Heart, Lung, And Blood Institute1985–1987
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
